Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 3Sarcoma 2Head & Neck 2Genitourinary 2Endocrine 2Dermatologic 2Thoracic 1Other solid neoplasm 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1883Lung Neoplasms 1308Small Cell Lung Carcinoma 329Colorectal Neoplasms 271Breast Neoplasms 243Melanoma 221Neoplasms 218Ovarian Neoplasms 193Neoplasm Metastasis 181Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 152Stomach Neoplasms 143Head and Neck Neoplasms 120Carcinoma, Renal Cell 119Triple Negative Breast Neoplasms 111Esophageal Neoplasms 109Prostatic Neoplasms 107Endometrial Neoplasms 98Uterine Cervical Neoplasms 97Urinary Bladder Neoplasms 89Mesothelioma 88Colonic Neoplasms 86Mesothelioma, Malignant 81Carcinoma, Hepatocellular 74Brain Neoplasms 70Sarcoma 64Disease 63Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Liver Neoplasms 49

Interventions

atezolizumab 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Mucinous × Thoracic × 1 year × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡